The Position We are seeking a talented and motivated individual for a Postdoctoral Research Fellowship in the PET imaging laboratory within the Department of Biomedical Imaging, part of our Research and Development organization. The department is well-equipped for PET radiochemistry, quantitative preclinical imaging, and bench work aimed at validating the imaging reagents and methods. The successful candidate is expected to establish and apply PET imaging reagents and methods to help us measure the presence of key cell populations and markers of their activity in preclinical models spanning neurodegeneration, cancer, and their response to novel therapeutics. This will involve the use of PET and optical reporter gene technologies, as well as targeted ligands based on small molecules, peptides, or antibodies as appropriate. For more information on Simon Williams lab, please visit: https:\/\/www.gene.com\/scientists\/our-scientists\/simon-williams Information about the postdoctoral program at Genentech can be found at http:\/\/www.gene.com\/careers\/academic-programs\/postdocs. Who We Are A member of the Roche Group, Genentech has been at the forefront of the biotechnology industry for more than 40 years, using human genetic information to develop novel medicines for serious and life-threatening diseases. Genentech has multiple therapies on the market for cancer & other serious illnesses. Please take this opportunity to learn about Genentech where we believe that our employees are our most important asset & are dedicated to remaining a great place to work. The next step is yours. To apply today, click on the \Apply online\ button. Genentech is an equal opportunity employer & prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity\/expression, national origin\/ancestry, age, disability, marital & veteran status. For more information about equal employment opportunity, visit our .
Website : http://www.gene.com
Considered the founder of the industry, Genentech, now a member of the Roche Group, has been delivering on the promise of biotechnology for over 35 years. At Genentech, we use human genetic information to discover, develop, manufacture and commercialize medicines to treat patients with serious or life-threatening medical conditions. Today, we are among the world's leading biotech companies, with multiple products on the market and a promising development pipeline.